A study involving 6,000 adults revealed that weight-loss injections can nearly halve the risk of obesity-related cancers, presenting a transformative opportunity for preventive cancer medicine. Researchers found that while bariatric surgery resulted in more weight loss, weight-loss injections, especially GLP-1 receptor agonists, offered a larger protective effect against cancer than previously understood. These findings highlight the potential of such medications to reduce inflammation and cancer risk, with newer drugs promising further benefits but requiring more investigation to ensure safety regarding other cancer types.
The findings of this landmark study suggest that weight-loss injections can significantly reduce the risk of obesity-related cancers, potentially changing future preventive cancer strategies.
Obesity is linked to 13 different cancers, and while traditional weight loss helps, weight-loss injections may provide an even greater protective effect.
Collection
[
|
...
]